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Abstract
Background: Increasingly, scholars argue that de-implementation is a distinct concept from implementation;
factors contributing to stopping a current practice might be distinct from those that encourage adoption of a new
one. One such distinction is related to de-implementation outcomes. We offer preliminary analysis and guidance on
de-implementation outcomes, including how they may differ from or overlap with implementation outcomes, how
they may be conceptualized and measured, and how they could be measured in different settings such as clinical
care vs. community programs.
Conceptualization of outcomes: We conceptualize each of the outcomes from Proctor and colleagues’ taxonomy
of implementation outcomes for de-implementation research. First, we suggest key considerations for researchers
assessing de-implementation outcomes, such as considering how the cultural or historical significance to the
practice may impact de-implementation success and, as others have stated, the importance of the patient in
driving healthcare overuse. Second, we conceptualize de-implementation outcomes, paying attention to a number
of factors such as the importance of measuring outcomes not only of the targeted practice but of the deimplementation process as well. Also, the degree to which a practice should be de-implemented must be
distinguished, as well as if there are thresholds that certain outcomes must reach before action is taken. We include
a number of examples across all outcomes, both from clinical and community settings, to demonstrate the
importance of these considerations. We also discuss how the concepts of health disparities, cultural or community
relevance, and altruism impact the assessment of de-implementation outcomes.
Conclusion: We conceptualized existing implementation outcomes within the context of de-implementation,
noted where there are similarities and differences to implementation research, and recommended a clear
distinction between the target for de-implementation and the strategies used to promote de-implementation. This
critical analysis can serve as a building block for others working to understand de-implementation processes and
de-implement practices in real-world settings.
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Contributions to the literature
 Research on de-implementation is increasingly becoming a
focus of implementation researchers. Guidance on how to
conceptualize de-implementation outcomes is critical for
moving this area forward.

 When conducting de-implementation research, it is important to measure outcomes, such as acceptability, not only of
the targeted practice but of the de-implementation process as
well.

 Assessing outcomes at the non-provider-level (i.e., the patient, consumer, or other receiver of the practice) is also critical in de-implementation studies, due to the possible
cultural or historical significance to the practice that will impact de-implementation success.

Introduction
Increasingly, scholars argue that de-implementation is a distinct concept from implementation; factors contributing to
stopping a current practice might be distinct from those that
encourage adoption of a new one. De-implementation is defined as reducing or stopping the use or delivery of services
or practices that are ineffective, unproven, harmful, overused,
or inappropriate [1]. Other terms for de-implementation
seen in the literature include de-adoption, discontinuation,
dis-investment, and even mis-implementation [2]. The rationale for focusing on de-implementation often centers on
decreasing healthcare or other costs, reducing unnecessary
treatments that may harm or burden the patient or client, or
simply replacing an existing practice with a new, more effective one [3–6]. Several research fields have contributed to the
de-implementation literature including medical or clinical research, health services, health policy, and of course, implementation science [4, 7–9].
In the field of implementation science, de-implementation
research is garnering increasing attention. A search for the
keyword “de-implementation” in the journal Implementation Science did not return any articles from the journal’s inception in 2006 through 2011. Only 2 articles on the topic
were found in 2012. From 2012 to 2016 there were, on average, 2.4 articles (range, 1–4) returned under the keyword
search for “de-implementation” per year. However, in 2017
the search returned seven articles related to deimplementation and eight articles in 2018, demonstrating a
marked increase in interest in this area. Further, this rudimentary search may be underestimating the number of articles published in the area given the use of alternate terms
for de-implementation. In addition to publications, the
number of funded grants in the de-implementation area has
also increased. Norton and colleagues recently identified 20
grants funded on the topic between 2000 and 2017, with
over half of these between 2015 and 2016 (n = 11) [1].
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Given the groundswell of interest in deimplementation research, guidance on how to optimally
conceptualize and conduct this type of research is
needed. To date, researchers have offered guidance on
topics such as defining de-implementation and determining what practices or interventions should be targeted for de-implementation [5, 6, 10–12]. While these
efforts are imperative for moving the area forward, there
are still critical gaps that may be inhibiting the advancement of de-implementation research. One such gap is
related to de-implementation outcomes.
After their analysis of funded de-implementation grants,
Norton, Kennedy, and Chambers [1] outline recommendations for raising the profile of de-implementation research.
One of these includes the synthesis and conceptualization
of de-implementation outcomes [1]. Historically, the field
of implementation science has recognized the value of
defined outcomes. Proctor and colleagues’ seminal paper
outlining eight implementation outcome categories [13] has
been cited over 1000 times. This established outcome
framework has served as a grounding point for countless
research studies and increasingly, newly proposed instruments/measures [14]. It is our goal to offer discussion and
preliminary guidance on de-implementation outcomes, including how they may differ from or overlap with implementation outcomes, how they may be conceptualized and
measured, and how they could be measured in different settings such as clinical care vs. community programs.
Specifically, we make two key points: First, we suggest key
considerations for researchers assessing de-implementation
outcomes, such as considering how the cultural or historical
significance to the practice may impact de-implementation
success and, as others have stated, the importance of the
patient in driving healthcare overuse [15]. Second, we
conceptualize de-implementation outcomes, paying attention to a number of factors such as the importance of measuring outcomes not only of the targeted practice but of the
de-implementation process as well. Also, the degree to which
a practice should be de-implemented must be distinguished,
as well as if there are outcome thresholds before action is
taken. We include a number of examples across all outcomes, both from clinical and community settings, to demonstrate the importance of these considerations.
Key considerations

Before discussing our conceptualization of outcomes, an
overarching theme that we feel is critical to include in
the conceptualization of de-implementation outcomes is
the importance of patients, consumers, and community
members (henceforth called “stakeholders”), as we argue
it is an important factor when conceptualizing deimplementation outcomes. In implementation research,
the practice being implemented is usually the most effective, evidence-based, “gold standard” care. However,
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in de-implementation research, practices are being
stopped/removed, and this could be met with a variety
of different reactions from stakeholders that may be
unique to de-implementation. Below we discuss some of
these reactions, the possible reasons for them, and how
these reactions relate to de-implementation outcomes.
Health disparities

Health disparities are differences and/or gaps in the
quality of health and healthcare across different groups,
as defined by race, ethnicity, socio-economic status,
rural/urban location, and other factors [16]. As it relates
to de-implementation, the disparity of access to and
quality of healthcare between groups means that historically some groups—particularly minority groups—have
not achieved health equity and have not always received
the best or even the baseline appropriate level of care
[17]. As such, it is understandable that some stakeholders might be suspicious or resistant to deimplementation efforts and see it as an attempt to ration/withhold access to evidence-based care or researchbased interventions. If a stakeholder perceives they are
already not receiving the care they should be, deimplementation efforts could further that feeling and
foster distrust in the provider, healthcare system, social
service system, etc. Furthermore, this distrust could
strain a relationship with stakeholders that may already
be fragile due to the historic nature of bias and discrimination in healthcare [18]. In other words, if a stakeholder already suspects they are being discriminated
against and not receiving equal access to evidence-based
practices, de-implementation efforts could understandably be seen as further evidence of this discrimination.
Related to this, black and Hispanic patients are more
likely to receive low-value healthcare practices such as
imaging for low-back pain and bone density testing [19,
20] and as a result, may be more often presented with
de-implementation efforts than their white counterparts.
Community or cultural relevance

Some practices may have significant relevance or importance to a community or culture, and as a result, stakeholders could question or resist de-implementation
efforts. For example, feeding practices of parents have a
basis in cultural values and shared experiences of communities. Targeting practices known to be detrimental for removal can stir unintended reactions among stakeholders.
For example, in our ongoing work of de-implementation
of detrimental feeding practices, adults’ practices, such as
encouraging children to eat to be polite (e.g., “no thank
you” bites), may undermine children’s ability to selfregulate and tune in to biological signs of hunger. However, this practice maintains social norms about food serving as love and connection. Such realities in the lives of
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community stakeholders impact the complexity of deimplementation efforts. Further, when asking educators to
reduce practices of pressuring children to eat, educators
described feeling as if that ignored the reality of the food
insecurity they fear for children [21] and what they experience in their own lives [22, 23]. In the clinical setting, the
practice of vaginal douching has a strong cultural and
community aspect. Some racial and ethnic groups are
more likely to douche, and women often learn about the
practice from other women in their families or communities [24, 25]. Attempts to discuss the discontinuation of
this practice must be done with the understanding that is
part of the stakeholder’s community or culture [24, 26].
Therefore, community or culture relevance should be considered when assessing de-implementation outcomes.
Altruism

For many practices targeted for de-implementation, stakeholder factors are not always prioritized. In the clinical
setting, perhaps the most well-known example of this is
the unnecessary prescribing of antibiotic medications.
While there are some negative consequences to the stakeholder in this instance such as side effects from the unnecessary medication, the greater incentive to stop
unnecessary antibiotic prescribing is at the populationlevel with the threat of antibiotic-resistant bacteria. In this
example, the stakeholder—who may be expecting antibiotics because they have received them in the past—may
not be motivated to forego the antibiotics because not
only do they individually not benefit from it but the risk
(e.g., side effects) may seem relatively benign. Explaining
and convincing the stakeholder that they should forego
antibiotics for the overall good of the population—especially when they personally do not assume considerable
risk individually—could prove challenging. This would require stakeholders to act primarily in an altruistic manner
and, given the discussion of health equity and culture relevance above, this may be difficult. In fact, research has
shown that when de-implementation was explained to patients with an altruistic pitch, patients did not respond favorably and furthermore rated the providers making the
altruistic pitch more negatively [27]. In this study, researchers used written vignettes to assess whether patients
responded differently when their physicians’ reasoning for
withholding low-value care included an altruism component (e.g., taking antibiotics for a sinus infection could result in antibiotic resistance for others). They found no
difference in patients’ requests for antibiotics when the altruistic pitch was included but did find that patients rated
those physicians who included the altruistic pitch worse
than physicians who did not [27]. This is another example
of an inherent difference between implementation and deimplementation. The psychological and emotional process
stakeholders are faced with when presented with new, best
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practices (implementation) is likely different from when
they are presented with the discontinuation of practices
they may expect or desire (de-implementation).
We are not the first to note these issues as they relate to
de-implementation [5, 10, 28, 29], but we hope to build on
that discussion and examine how this impacts deimplementation research methods, specifically outcome assessment. First, we believe these issues could affect acceptability and appropriateness. Even if all other relevant
aspects of a de-implementation study suggest the practice
is poised for successful de-implementation, if the stakeholder still finds the practice acceptable or appropriate then
de-implementation could be challenging at best and impossible at worst. We often see this type of barrier in the deimplementation of antibiotic prescriptions, where providers
have reported that if the patient is insistent that they receive
antibiotics, the provider will relent and write the prescription even when the provider is aware of and believes all of
the reasons for not writing it [30, 31]. Second, because of
the concerns of health equity and minorities related to deimplementation, we believe it is especially important to
measure Reach, the representativeness of the participants in
a de-implementation study. Ensuring de-implementation
efforts do not further health disparities is a critical and ethical issue de-implementation researchers must be aware of
and work to avoid. Third, these issues could also affect the
feasibility of de-implementing a practice. With the example
of antibiotic prescriptions, if the provider is uncomfortable
with patients’ resistance or agitation to being told
they are not receiving antibiotics, that provider may
relent entirely and stop all efforts to reduce writing
prescriptions for antibiotics.
In implementation studies, it may not always be necessary to measure outcomes at the stakeholder-level. However, given the unique considerations and issues of deimplementation outlined above, we believe researchers
conducting de-implementation studies should prioritize
the assessment of key outcomes at the stakeholder level
and how these issues affect de-adoption. We understand
that stakeholder-level data are often time-consuming
and difficult to collect, but if the field desires to understand how and when de-implementation efforts succeed
or fail, understanding the role and magnitude of these
stakeholder issues is imperative.

Conceptualizing de-implementation outcomes
We draw from existing outcomes in our conceptualization
of de-implementation outcomes [13]. In 2011, Proctor
and colleagues published a taxonomy of implementation
outcomes that has become widely used across the field
[13]. These outcomes include acceptability, adoption, appropriateness, feasibility, fidelity, cost, penetration, and
sustainability. We discuss each of these outcomes as they
relate to de-implementation.
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In addition to the conceptualization of these outcomes
for de-implementation purposes, we also drew on each
of our substantive areas of expertise to provide illustrative examples of how these outcomes might be conceptualized and measured in different settings including
clinical and community settings. These outcomes are
summarized in Table 1.
We use the following definitions throughout the paper.
When we refer to the “practice” we are referring to the
intervention, treatment, service, or program that is the
target of de-implementation. When we refer to “providers” we are referring to the individual who delivers
the practice. This could be physicians or teachers or
others. When we refer to “stakeholders” we are referring
to non-providers who have a stake in the practice. This
includes patients and students but could also include
teachers (if they are not providing the practice to students), parents, community members, or others.

Acceptability

The definition of acceptability as an implementation outcome is “the perception among implementation stakeholders that a given treatment, service, practice, or
innovation is agreeable, palatable, or satisfactory.” When
considering this outcome for de-implementation research,
we identified multiple ways it could be conceptualized and
used, depending on the purpose of the research. Acceptability could be measured as the degree to which stakeholders and providers perceive a given practice as not
agreeable, palatable, or satisfactory. This is the same definition as it would be for implementation research except
the focus is on how unacceptable the practice is. In deimplementation research, acceptability measured in this
way may be used to identify practices that are candidates
for de-implementation. If stakeholders or providers no
longer find a practice acceptable or to have low acceptability—for whatever reason—then they may be more likely to
de-implement that practice.
Another way acceptability could be conceptualized
and measured for de-implementation research is the
perception among providers or stakeholders that stopping or de-implementing the practice, versus the practice
itself, is acceptable, palatable, or satisfactory. While nuanced, this definition distinguishes the acceptability of
the de-implementation process from the acceptability of
the practice targeted for de-implementation. It may
seem logical to assume that if a stakeholder or provider
finds a practice unacceptable, they would find stopping
or de-implementing that practice an acceptable thing to
do. However, we can identify situations in which a provider’s or stakeholder’s opinion about the acceptability
of a practice may not align with their opinion about the
acceptability of stopping that practice.

The degree to which the entire or whole
practice is stopped for the right people and in
the right contexts

The degree to which the practice is stopped
equally, across patients/clients and providers

Practice

Stakeholders

Fidelity

The extent to which the practice is
discontinued within a service setting and its
subsystems

The extent to which a practice’s discontinuation The number of physicians in the intensive care unit who are
is maintained
still no longer delivering the bundled intervention six
months after the de-implementation strategies have
discontinued.

Penetration

Sustainability

The number of intensive care units across a large, healthcare
system that stops delivering the bundled intervention.

The number of physicians in the intensive care unit who
stop delivering the bundled intervention.

The number of components of a bundled intervention for
ventilated patients that are stopped.

The feasibility of stopping some practices that are required
to provide to meet quality improvement metrics.

The extent to which a practice can be
successfully stopped within a given agency or
setting

Emergency room providers may not find the idea of
stopping smoking cessation as appropriate because they
need to provide this to patients to meet hospital quality
metrics.

Feasibility

The degree to which the idea of stopping a
practice is appropriate given a setting, provider,
consumer, issue, or problem.

Process

Emergency room providers may not find smoking cessation
as an appropriate practice to provide in the emergency
setting.

The cost of the de-implementation strategies or The costs associated with using local technical assistance as
the costs-saved from stopping the practice.
a de-implementation strategy.
The costs saved by not ordering routine lipid panels as
screening tests for cardiovascular disease.

The degree to which a practice is perceived to
not fit, have relevance, or be compatible for a
given setting, provider, consumer, issue, or
problem.

Appropriateness Practice

It is important to ask the stakeholders of a practice
if they find the practice and the idea of stopping
that practice acceptable.

Additional considerations

It is important to understand how stakeholders’
beliefs on acceptability and appropriateness impact
providers’ beliefs on the feasibility of deimplementation.
It is also important to consider structural,
organizational, or procedural barriers to the
feasibility of de-implementation.

It is important to ask the end-users of a practice if
they find the practice and the idea of stopping that
practice appropriate.

A physician makes the decision to stop ordering imaging for To avoid confusion between implementation and
patients with low-back pain.
de-implementation studies, we recommend calling
this de-adoption.

Cost

The initial decision or action to stop using a
practice

Adoption

The degree to which the idea of stopping a
Providers may find stopping the referral of patients to 12practice is perceived as not agreeable, palatable, step programs as unacceptable if the providers cannot proor satisfactory
vide a more acceptable treatment in its place, such as
methadone.

Process

Providers may find 12-step programs for opioid use disorders unacceptable.

The degree to which a practice is perceived as
not agreeable, palatable, or satisfactory

Practice

Examples

Acceptability

Definition

Target of
measurement
(if applicable)

Deimplementation
outcome

Table 1 Conceptualization of de-implementation outcomes
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For example, sometimes de-implementation occurs simply because a new, better practice is to be implemented
and replace the old one (i.e., the evidence has evolved and
improved). In those cases, the original practice may still
be acceptable to some at the same time stopping that
practice is also acceptable. For example, there are multiple
“generations” of anti-depressant medications, where new
medications are introduced and are generally considered
superior to the older medications, for various reasons.
Providers may find the old medications acceptable but
also find replacing them with the new, better medications
acceptable. In other cases, the practice may be acceptable
but it was never evidence-based and is now targeted for
de-implementation. In communities, for example, some
schools have been hesitant to stop the practice of corporal
punishment despite experts advocating for alternative
practices [32, 33]. Providers or stakeholders, even if they
agree the practice is not ideal, hold on to the way things
have been done in the past and describe fear for future
generations if the practice were to be stopped.
We recommend researchers who set out to measure
acceptability in de-implementation research be clear on
what question they are attempting to answer and what
target of measurement—the practice itself or the idea of
de-implementing it—they are assessing for acceptability. In
the event they are studying the de-implementation of one
practice coupled with the replacement of another, we believe it would be important to assess the acceptability of
both practices.
Adoption

For implementation purposes, the definition of adoption
is “the intention, initial decision, or action to try or employ an innovation or evidence-based practice.” The important component of adoption is that it is the initial
decision to use a practice. When considering how adoption may be conceptualized for de-implementation, it
could be conceptualized as the intention or initial decision to stop using a practice. This could be the first time
a provider decided, or at least indicated they had the
intention, to not order imaging for a patient presenting
with low-back pain. Subsequent decisions to not place
this order would move beyond adoption, but that initial
decision to try de-implementation could be considered
adoption. We recommend this simply be called deadoption in the context of de-implementation to avoid
any confusion with adoption.
Another conceptualization of de-adoption in deimplementation research is the degree to which the practice
is de-implemented equally. This may be at the stakeholderlevel (i.e., is the practice being stopped for some patients
and not others?) or at the provider-level (i.e., are some providers stopping and not others?). Whether or not a practice
is de-adopted equally may depend on if the intent is to stop
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the practice completely or just reduce its use. It may also
depend on if there is a replacement practice or not.
Appropriateness

The definition of appropriateness is “the perceived fit,
relevance, or compatibility of the innovation or
evidence-based practice for a given practice setting, provider, or consumer; and/or perceived fit of the
innovation to address a particular issue or problem.” To
conceptualize appropriateness for de-implementation research, we took a similar approach to acceptability.
Appropriateness could be conceptualized as when the
stakeholder or provider perceives the practice to not fit,
have relevance, or be compatible for a given setting, provider, consumer, issue, or problem. As with acceptability,
this measure of appropriateness may be most useful when
used to identify candidates for de-implementation. If a
stakeholder or provider no longer (or perhaps never did)
find the practice relevant or compatible then that practice
may be a prime target for de-implementation assuming
other relevant factors are present (e.g., the evidence is not
strong, it is not cost-effective, etc.). Appropriateness could
also be a measure of the appropriateness of the deimplementation process in a given practice setting, provider,
or consumer; and/or for a particular issue or problem. Like
acceptability, it may not always be the case that
practices perceived as inappropriate are selected for deimplementation. Therefore, we recommend deimplementation researchers consider if they want to
measure the appropriateness of the practice and/or the
de-implementation of it and to be clear when reporting
their findings what their target of measurement was.
Cost

The cost of an implementation effort varies according to
three components: the complexity of (1) the practice, (2)
the implementation strategies, and (3) the setting. Given
de-implementation inherently means stopping or reducing a practice, and in healthcare often a practice is targeted for de-implementation solely because it is costly
or not cost-effective, there may be cost savings and limited new costs with de-implementation alone. Cost savings could be a relevant measure of cost in the context
of de-implementation. One could measure the cost of
the practice to the healthcare system and to consumers
and how much is saved when the practice is stopped.
In other scenarios, a new practice is often being introduced in place of the old one, and therefore, implementation expenses are coupled with de-implementation
cost savings. Likewise, strategies to de-implement a
practice will likely have associated costs just as implementation strategies would and those could be measured
to help determine the true de-implementation costs. We
believe that with de-implementation efforts, just as with
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implementation efforts, the goal is more towards costeffectiveness as opposed to strict cost savings.
Given that one criterion for de-implementation is the targeting of potentially harmful practices, the cost of deimplementation should be considered in the greater context
of the benefit of the services or care provided. In some
cases, de-implementation of harmful practices that are free
or low-cost may take several years to demonstrate costeffectiveness given the upfront costs of de-implementation
strategies. For example, in the authors’ ongoing work, we
are investing considerable costs in strategies (e.g., peer
learning collaborative) to support the removal of harmful
feeding practices by early care and education teachers. The
cost savings of such efforts may not be evident within 1
school year, the typical time frame for studies in the school
setting due to logistical concerns. Concerted and similar efforts targeting adults in multiple contexts of a child’s life
over several years may be needed to realize costeffectiveness through improved child health. Researchers
should carefully consider the timeframe for assessing cost
in de-implementation research.
We also think cost is important to measure in deimplementation because the assumed cost savings associated
with stopping or reducing a practice could have unintended
consequences for some providers. In rural areas, health care
providers are often operating on minimal budgets with little
room to absorb a reduction in revenue [34, 35]. If deimplementing a practice significantly reduces their income,
that may have an impact on how acceptable, for example,
the provider or hospital might view de-implementing that
practice. For example, cardiac catheterizations are not always
necessary and are costly [36, 37]. However, a rural hospital
that is equipped to conduct cardiac catheterizations likely
needs to conduct a certain number of them to break even
with the costs the hospital incurs to keep the necessary
equipment and staff in place to conduct them. If reducing
the number of cardiac catheterizations means the hospital
could lose revenue and possibly end up closing that lab and
no longer being able to offer that service, there is a strong
incentive for the hospital to continue to provide this service.
That is, cost considerations could drive views on the acceptability of de-implementation.

Feasibility

In implementation research, feasibility is defined as “the
extent to which a new treatment, or an innovation, can
be successfully used or carried out within a given agency
or setting.” Feasibility is often discussed in relation to
appropriateness and acceptability. If a provider finds a
practice acceptable and appropriate—they have mentally
bought into the practice—they still may find the practice
not feasible to adopt or implement due to structural,
organizational, or contextual barriers, for example.
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To conceptualize feasibility in de-implementation, we
must think about the extent to which a practice can be
feasibly stopped within a given agency or setting. Similar
to our thinking of cost, we may assume that because deimplementation is “simply” stopping a behavior, there
may not be structural or procedural barriers (e.g., equipment, staffing) to de-implementation. We may assume
that once a provider has made the decision to not provide that practice, they can simply proceed with the behavior of stopping, or de-adoption and deimplementation. However, just as with implementation,
there could be de-implementation feasibility issues that
prevent the stopping of a practice even if providers or
stakeholders personally want to stop.
For example, this may be especially relevant in clinical
settings in which structural factors related to electronic
health records, billing and coding practices, and policies
(such as those made by the Centers for Medicare and
Medicaid) may present as insurmountable barriers to
de-implementation. If a particular practice—a test or
procedure—is necessary for quality/safety oversight purposes, then providers may find that practice not feasible
to stop even if they find stopping that practice acceptable and appropriate. This exact issue has recently come
under scrutiny with the Medicare Merit-based Incentive
Payment System (MIPS)/Quality Payment Program
(QPP). The MIPS/QPP programs have 271 performance
measures that are the basis for the Centers for Medicare
and Medicaid Services value-based payment systems.
The American College of Physicians assessed the validity
(a combination of the impact, appropriateness, feasibility, specificity, and evidence behind the measure) of 86
of the 271 MIPS/QPP that were relevant to ambulatory
general internal medicine and found that only 37% were
considered valid; while 35% were not valid, and 28% had
uncertain validity [38]. Despite more than half of the
measures having uncertain or no validity, these measures
are still tied to performance measures; therefore, providers may not be able to feasibly stop using them even
if they find them unacceptable or inappropriate.
Therefore, while the de-implementation definition of
feasibility simply shifts the focus to the feasibility of stopping a practice rather than using or carrying out a practice,
our main recommendation for de-implementation researchers is to not assume that de-implementation is simpler than implementation processes, nor does it represent
solely a personal, behavioral decision. Instead, barriers beyond the individual—structural, organizational, contextual, etc.—could make de-implementation not feasible.
Fidelity

The definition of fidelity is “the degree to which an intervention was implemented as it was prescribed in the original protocol or as it was intended by the program
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developers.” In the context of de-implementation, fidelity
could be conceptualized as the quality of deimplementation. That is, fidelity would be the degree to
which the practice is de-implemented for the recommended persons in the recommended situations. For example, de-implementation fidelity would be reflected by
the practice being reduced or stopped for the recommended patients. Further, de-implementation strategies
would be applied judiciously to ensure a practice would
still be available and provided to patients for whom it is
appropriate, even if that is a small number of patients.
In addition to the conceptualization of fidelity as the
quality of de-implementation, removal of practices that
are not evidence-based could have an indirect influence
on fidelity to practices that are evidence-based. That is,
targets for de-implementation may compete with implementation of evidence-based innovations. In this case,
removal of the competing practices may improve fidelity
to implementation of the research evidence. In school
settings, for example, fidelity to evidence-based traumainformed care may be difficult in the face of blanket policies about school suspension and/or educator practices
that stigmatize students’ mental health concerns. Deimplementation of the latter may indirectly improve the
use of trauma-informed care practices. Researchers conducting de-implementation work should specify if their
fidelity measure is targeted at the quality of the deimplementation, the indirect effect on the quality of implementation of other research evidence, or both [39,
40].
Penetration

Proctor and colleagues define penetration as “the integration of a practice within a service setting and its subsystems.” The key word in this definition is subsystems.
Penetration specifically refers to the concept that a practice is spread throughout a setting and does not end
with a single entity. For example, a healthcare system
may be comprised of hospitals, outpatient care clinics,
specialty clinics, and long-term and post-acute care facilities. In a community setting, there are also networks
that extend across the country that have federal, state,
and local leadership and policies (e.g., Supplemental Nutrition Assistance Program). When measuring the penetration of an implementation effort one would look to
see the extent to which the practice was implemented
across all of these subsystems within the system. Penetration in a de-implementation study would be the extent to which a practice is discontinued within a service
setting and its subsystems. This concept is especially important for de-implementation research because of the
ongoing, large-scale campaigns to de-implement lowvalue care practices, such as the Choosing Wisely campaign [7]. The purpose of these campaigns is to have de-
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implementation efforts penetrate the system broadly,
and thus, penetration would be a key outcome measure
for these campaigns.
Sustainability

For implementation research, sustainability is defined as
“the extent to which a newly implemented treatment is
maintained or institutionalized within a service setting’s
ongoing, stable operations.” For de-implementation research, sustainability may be defined as the extent to
which a practice’s discontinuation is maintained. Once a
practice has been de-implemented, over time the practice may be re-implemented—intentionally or unintentionally—without continual efforts to maintain and
support initial de-implementation. This also relates to
feasibility and the possibility that structural, procedural,
or societal factors may inhibit or challenge deimplementation efforts in the long-term. Sustainability
after initial de-implementation could prove especially
challenging if counteracting factors remain strong forces
pushing that practice into use.

Conclusion
We have attempted to provide some guidance to deimplementation researchers on outcome measurement.
We conceptualized existing implementation outcomes
within the context of de-implementation, noted where
there are similarities and differences to implementation
research, and recommended a clear distinction between
the target for de-implementation and the strategies used
to promote de-implementation. We also highlighted the
critical role stakeholders play in de-implementation and
made recommendations for capturing this role in deimplementation studies.
There is much work to be done to further deimplementation methodology. High-yield areas include
linking these outcomes to specific measures, including
testing existing implementation measures such as the
Acceptability of Intervention Measure, Feasibility of
Intervention Measure, and Intervention Appropriateness
Measure [14] in de-implementation studies to assess
their fit and relevance. For many of the outcomes presented above, our conceptualizations may also be applicable to implementation outcomes, as there is always an
interest in measuring the status quo and change from
the status quo, and it may be possible to use the same
measures for both types of studies. If these and other
existing measures are not adequate for adaptation for
de-implementation measurement, there is a need to create valid, reliable de-implementation measures. Furthermore, research on whether or not a threshold exists for
these outcomes is needed. For example, for how long or
to what extent does an intervention need to be found
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unacceptable before the practice is officially deemed
“unacceptable”?
Also, with the conceptualization of these outcomes, it
is important to link them with theories, strategies, and
mechanisms for de-implementation. As we have discussed, it is reasonable to believe there are distinct differences
between
implementation
and
deimplementation. That is, we do not know if the existing
theories and strategies for implementation apply in the
context of de-implementation. Applying these theories
to de-implementation strategies and outcomes is critical
to building a solid foundation of de-implementation research. Likewise, we do not fully understand the mechanisms that drive implementation, and by extension, we
do not know if these mechanisms are the same for deimplementation. The critical analysis of deimplementation outcomes we offer in this paper can
serve as a piece of the methodological puzzle for others
working to understand de-implementation processes and
de-implement practices in real-world settings.
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